North America Neuropathic Pain Market – Industry Trends and Forecast to 2030

Analyse et taille du marché de la douleur neuropathique

La douleur neuropathique est provoquée par une lésion ou une maladie du système somatosensoriel, notamment des fibres périphériques (fibres Aβ, Aδ et C) et des neurones centraux. Elle touche 7 à 10 % de la population générale. De multiples causes de douleur neuropathique ont été décrites et son incidence est susceptible d'augmenter en raison du vieillissement de la population mondiale, de l'incidence accrue du diabète sucré et de l'amélioration de la survie au cancer après chimiothérapie.           

Data Bridge Market Research analyse que le marché, qui était de 2,60 milliards USD en 2022, devrait grimper à 5,20 milliards USD d'ici 2030 et devrait connaître un TCAC de 9,0 % au cours de la période de prévision de 2023 à 2030. Les « dispositifs de stimulation de la moelle épinière (SCS) » dominent le segment type du marché de la douleur neuropathique en raison de la prévalence croissante des maladies chroniques. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également des analyses approfondies d'experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché de la douleur neuropathique

Définition du marché

Une forme de douleur persistante provoquée par une lésion ou un dysfonctionnement du système neurologique, en particulier du système nerveux périphérique, est connue sous le nom de neuropathie ou simplement de douleur « neuropathique ». La douleur neuropathique, contrairement à la douleur nociceptive conventionnelle, est provoquée par une signalisation et un traitement anormaux des impulsions de douleur à l'intérieur du système nerveux lui-même. La douleur nociceptive conventionnelle résulte d'une lésion tissulaire (comme une blessure ou une inflammation).

Dynamique du marché de la douleur neuropathique

Conducteurs

• Prévalence croissante des maladies chroniques

La prévalence croissante de maladies chroniques telles que le diabète, le VIH/SIDA et le cancer dans la région contribue à l’incidence de la douleur neuropathique. À mesure que ces pathologies deviennent plus courantes, la demande de solutions efficaces de gestion de la douleur augmente.

• Des thérapies alternatives de plus en plus disponibles

Il existe des possibilités d’élargir la gamme de traitements disponibles pour la douleur neuropathique en raison de la popularité croissante des thérapies complémentaires et alternatives telles que l’acupuncture et la phytothérapie.

• Augmentation de la population gériatrique

La population de la région MEA vieillit, ce qui entraîne un changement démographique. Les personnes âgées sont plus susceptibles de souffrir de douleurs neuropathiques, ce qui augmente le nombre de patients nécessitant des soins et des services de gestion de la douleur.

Opportunités

• Le tourisme médical en plein essor

Certains pays du Moyen-Orient et de l'Afrique se présentent comme des destinations de tourisme médical, attirant les personnes à la recherche de thérapies de gestion de la douleur de premier ordre à des coûts raisonnables

• Augmentation des dépenses de santé

Some nations in the MEA region are making investments in the construction of healthcare facilities such hospitals, clinics, and specialised pain management facilities. Patients with neuropathic pain may have easier access to pain management therapies as a result

Restrains/Challenges

• Strict Regulations

The regulatory framework for medical devices and pharmaceuticals can be complicated and differ from one nation to another. For businesses looking to advertise neuropathic pain therapies in the area, this may present difficulties

• Economic Factors

Patients may find it challenging to pay for the expense of neuropathic pain drugs and therapies due to the region's economic inequalities. It's possible that many people lack insurance coverage for these procedures

• Limited Access to Healthcare

In many parts of the Middle East and Africa, access to healthcare is limited, especially in rural areas. This can result in delayed diagnosis and treatment of neuropathic pain

• Limited Research Funding 

The discovery of novel and efficient treatments for neuropathic pain may be slowed down in some nations due to inadequate financing for medical research and development

This neuropathic pain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neuropathic pain market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

North America Neuropathic Pain Market Scope

The neuropathic pain market is segmented on the basis of the type, product type, procedure, technology, modality, mode of purchase, pain type, indication, end-user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Type

• Spinal Cord Stimulation (SCS) Devices
• External Peripheral Nerve Stimulation
• Transcutaneous Electrical Nerve Stimulation (TENS) Devices

Product Type

• Rechargeable
• Non-Rechargeable

Procedure

• Invasive
• Non-Invasive

Technology

• Transcutaneous Electrical Nerve Stimulation
• Transcranial Magnetic Stimulation
• Respiratory Electrical Stimulation

Modality

• Stationary
• Portable

Mode of Purchase

• Over-the-Counter Devices
• Prescription-Based Devices

Pain Type

• Peripheral Neuropathy
• Entrapment Neuropathy
• Phantom Limb Neuropathy
• Trigeminal Neuralgia
• Post Herpetic Neuralgia (PHN)
• Post Traumatic Neuropathy
• Foot Pain
• Coccydynia

Indication

• Spinal Stenosis
• Chemotherapy-Induced Peripheral Neuropathy
• Diabetic Neuropathy
• Others

End-Users

• Hospitals
• Clinics
• Home Healthcare
• Ambulatory Surgical Centers
• Others

Distribution Channel

• Direct Tender
• Third Party Distributor
• Others

Global Neuropathic Pain Market Regional Analysis/Insights

The neuropathic pain market is analysed and market size information is provided by the type, product type, procedure, technology, modality, mode of purchase, pain type, indication, end-user and distribution channel as referenced above.

The countries covered in the neuropathic pain market report are U.S., Canada and Mexico

U.S. is dominating the North America market owing to advancement in healthcare expenditure and funding.

Canada is the fastest growing in the North America market owing to rising prevalence of chronic diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Neuropathic pain market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Neuropathic Pain Market Share Analysis

Neuropathic pain market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to neuropathic pain market.

Some of the major players operating in the neuropathic pain market are:

• AVNS (U.S.)
• B. Braun Melsungen AG (Germany)
• Medtronic (U.S.)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• Omron Healthcare Inc. (Japan)
• NEVRO CORP (U.S.)
• electroCore, Inc.(U.S.)
• Cirtec (Switzerland)
• Stimwave LLC (U.S.)
• SPR Therapeutics (U.S.)
• NeuroMetrix, Inc. (U.S.)
• Integer Holdings Corporation (U.S.)
• SunMed (U.S.)

SKU-63253